OTC : IDXG

Interpace Biosciences, Inc. — Earnings Estimates

$1.7 USD

$0.09 (5.59%)

Volume
13.7K
Average Volume
5.5K
Market Capitalization
$47.09M
P/E Ratio
0.32
Dividend Yield
0.00%
Price Target
Year High
$2.40
Year Low
$0.77
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.22

Annual earnings financials

IDXG financial data with annual/quarterly toggle

IDXG GAAP EPS - Annual & Quarterly

IDXG Sales Revenue - Annual & Quarterly

IDXG Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

IDXG Estimated and Actual Revenue by Quarter
IDXG Estimated and Actual EPS by Quarter
IDXG Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-03-31 1 908.64K 908.64K 908.64K 61916 61916 61916
2028-12-31 1 820.71K 820.71K 820.71K 55924 55924 55924
2028-09-30 1 762.08K 762.08K 762.08K 51929 51929 51929
2028-06-30 1 703.46K 703.46K 703.46K 47935 47935 47935
2028-03-31 1 791.4K 791.4K 791.4K 53927 53927 53927
2027-12-31 1 732.77K 732.77K 732.77K 49932 49932 49932
IDXG Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-03-31 1 3.05M 3.05M 3.05M 8.2M 8.2M 8.2M
2028-12-31 1 -277.07K -277.07K -277.07K 7.4M 7.4M 7.4M
2028-09-30 1 -2.22M -2.22M -2.22M 6.88M 6.88M 6.88M
2028-06-30 1 -5.26M -5.26M -5.26M 6.35M 6.35M 6.35M
2028-03-31 1 -1.94M -1.94M -1.94M 7.14M 7.14M 7.14M
2027-12-31 1 -6.93M -6.93M -6.93M 6.61M 6.61M 6.61M
IDXG Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-03-31 1 15.5M 15.5M 15.5M 1 0.11 0.11 0.11
2028-12-31 1 14M 14M 14M 1 -0.01 -0.01 -0.01
2028-09-30 1 13M 13M 13M 1 -0.08 -0.08 -0.08
2028-06-30 1 12M 12M 12M 1 -0.19 -0.19 -0.19
2028-03-31 1 13.5M 13.5M 13.5M 1 -0.07 -0.07 -0.07
2027-12-31 1 12.5M 12.5M 12.5M 1 -0.25 -0.25 -0.25